Cholera Toxin and Heat-Labile Enterotoxin Activate Human Monocyte-Derived Dendritic Cells and Dominantly Inhibit Cytokine Production through a Cyclic AMP-Dependent Pathway
Open Access
- 1 October 2002
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 70 (10) , 5533-5539
- https://doi.org/10.1128/iai.70.10.5533-5539.2002
Abstract
Cholera toxin (CT) and heat-labile enterotoxin (LT) are powerful mucosal adjuvants whose cellular targets and mechanism of action are unknown. There is emerging evidence that dendritic cells (DC) are one of the principal cell types that mediate the adjuvant effects of these toxins in vivo. Here we investigate the effects of CT and LT on the maturation of human monocyte-derived DC (MDDC) in vitro. We found that an enzymatically active A domain is necessary for both CT and LT to induce the maturation of MDDC and that this activation is strictly cyclic AMP (cAMP) dependent. ADP-ribosylation-defective derivatives of these toxins failed to induce maturation of MDDC, whereas dibutyryl-cyclic-3′,5′-AMP and Forskolin mimic the maturation of MDDC induced by CT and LT. In addition, an inhibitor of cAMP-dependent kinases, Rp-8-Br-cAMPs, blocked the ability of CT, LT, and Forskolin to activate MDDC. CT, LT, dibutyryl-cyclic-3′,5′-AMP, and Forskolin also dominantly inhibit interleukin 12 and tumor necrosis factor alpha production by MDDC in the presence of saturating concentrations of lipopolysaccharide. Taken together, these results show that the effects of CT and LT on MDDC are mediated by cAMP.Keywords
This publication has 38 references indexed in Scilit:
- Enterotoxin Adjuvants Have Direct Effects on T Cells and Antigen‐Presenting Cells That Result in Either Interleukin‐4–Dependent or –Independent Immune ResponsesThe Journal of Infectious Diseases, 2000
- Structural Basis for the Differential Toxicity of Cholera Toxin and Escherichia coli Heat-labile EnterotoxinPublished by Elsevier ,1999
- Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunitVaccine, 1998
- Accumulating Evidence Suggests That Several AB-Toxins Subvert the Endoplasmic Reticulum-Associated Protein Degradation Pathway To Enter Target CellsBiochemistry, 1997
- Mechanisms for Mucosal Immunogenicity and Adjuvancy of Escherichia coli Labile EnterotoxinThe Journal of Infectious Diseases, 1996
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.The Journal of Experimental Medicine, 1994
- Effectiveness of cholera toxin B subunit as an adjuvant for nasal influenza vaccination despite pre-existing immunity to CTBVaccine, 1989
- Long‐Term Cholera Antitoxin Memory in the Gut can be Triggered to Antibody Formation Associated with Protection within Hours of an Oral Challenge ImmunizationScandinavian Journal of Immunology, 1987
- Size and Structure of the Cholera Toxin Molecule and Its SubunitsThe Journal of Infectious Diseases, 1976
- Cholera Toxin: Interaction of Subunits with Ganglioside G M1Science, 1974